14-day Premium Trial Subscription Try For FreeTry Free
$13.56
-0.180 (-1.31%)
At Close: May 01, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $12.20 $17.80 Wednesday, 1st May 2024 ENTA stock ended at $13.56. This is 1.31% less than the trading day before Tuesday, 30th Apr 2024. During the day the stock fluctuated 5.63% from a day low at $13.51 to a day high of $14.27.
90 days $11.01 $17.80
52 weeks $8.08 $37.14

Historical Enanta Pharmaceuticals prices

Date Open High Low Close Volume
May 07, 2021 $51.29 $51.50 $48.50 $48.50 140 169
May 06, 2021 $52.32 $52.32 $50.13 $51.00 128 614
May 05, 2021 $51.36 $52.42 $50.42 $52.07 97 355
May 04, 2021 $52.87 $53.50 $51.16 $51.41 95 692
May 03, 2021 $51.39 $53.76 $50.13 $53.11 117 798
Apr 30, 2021 $50.96 $52.09 $50.11 $50.74 98 380
Apr 29, 2021 $50.92 $51.93 $50.73 $51.35 53 737
Apr 28, 2021 $49.96 $50.97 $49.42 $50.84 74 692
Apr 27, 2021 $50.86 $50.86 $50.08 $50.27 87 083
Apr 26, 2021 $50.19 $50.63 $49.70 $50.41 108 541
Apr 23, 2021 $52.34 $52.45 $50.16 $50.27 130 587
Apr 22, 2021 $52.65 $53.46 $51.02 $52.39 90 260
Apr 21, 2021 $51.23 $52.56 $50.70 $52.33 108 426
Apr 20, 2021 $49.30 $51.29 $49.30 $51.10 65 452
Apr 19, 2021 $50.52 $50.52 $49.01 $49.87 77 949
Apr 16, 2021 $52.03 $52.46 $50.49 $50.68 103 235
Apr 15, 2021 $50.65 $52.89 $50.65 $51.76 111 027
Apr 14, 2021 $49.50 $51.15 $48.81 $50.65 108 860
Apr 13, 2021 $48.13 $49.54 $48.13 $49.41 83 449
Apr 12, 2021 $49.14 $49.20 $47.80 $48.48 120 507
Apr 09, 2021 $49.27 $49.49 $47.99 $48.75 122 545
Apr 08, 2021 $48.73 $49.48 $48.03 $49.31 124 244
Apr 07, 2021 $49.37 $49.37 $48.17 $48.63 98 119
Apr 06, 2021 $50.38 $50.88 $49.57 $49.69 144 777
Apr 05, 2021 $51.20 $51.68 $50.12 $50.56 72 944
Click to get the best stock tips daily for free!

About Enanta Pharmaceuticals

Enanta Pharmaceuticals Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and license agreement with Abbott Laboratories to identify, develop, and commercialize HCV NS3 and NS3/4A pro... ENTA Profile

Golden Star

Ticker Date Change Price
HRB Apr 29 1.00% $47.23
LYG Apr 29 0.391% $2.56
ORA Apr 29 1.95% $64.48
ETSY Apr 26 3.43% $67.43
DHT Apr 24 0.98% $11.28
LPLA Apr 19 1.10% $262.59
MLI Apr 19 7.29% $52.28
PFLT Apr 18 1.33% $11.25
DOOR Apr 18 0.94% $131.39
OCSL Apr 17 0.360% $19.43
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT